Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Family Studies of Whim Syndrome

David C. Dale, MD, Emily Dick, BA, Merideth L. Kelley, MSc, Vahagn Makaryan, MD, Jim Connelly, MD, Audrey Anna Bolyard, RN, BS

Blood (2019) 134 (Supplement_1): 215.

https://doi.org/10.1182/blood-2019-126234

Published: 2019

Journal Articles

Extended Genetic Testing in Severe Congenital Neutropenia May Identify Mutations That Inform Therapy

Daniel C. Link, MD, Vahagn Makaryan, MD, David H Spencer, MDPhD, Jun Xia, PhD, Audrey Anna Bolyard, RN, BS, David C Dale, MD

Blood (2018) 132 (Supplement 1): 2401.

https://doi.org/10.1182/blood-2018-99-116712

Published: 2018

Journal Articles

Determination of Phase 3 Dose for X4P-001 in Patients with WHIM Syndrome

David C Dale, MD, Frank Caleb Firkin, MD, Audrey Anna Bolyard, RN, BS, Merideth L. Kelley, MSc, Emily Dick, BA, Sonja Hartmann, PhD, Karen Brown, PhD, Tarek M Ebrahim, MD, Kenneth J Gorelick, MD, Sudha Parasuraman, MD

Blood (2018) 132 (Supplement 1): 1102.

https://doi.org/10.1182/blood-2018-99-119840

Published: 2018

Journal Articles

The Effect of the MK0339 Neutrophil Elastase Inhibitor on Proliferation and Maturation of iPSC Derived from Patients with ELANE, TCIRG1 and Whim Syndrome Associated Neutropenia

Vahagn Makaryan, MD, Breanna Fletcher, BSc, Merideth L. Kelley, MS, David Dale, MD

Blood (2017) 130 (Supplement 1): 545.

https://doi.org/10.1182/blood.V130.Suppl_1.545.545

Published: 2017

Journal Articles

How I treat warts, hypogammaglobulinemia, infections, and myelokathexis syndrome

Raffaele Badolato, Jean Donadieu, the WHIM Research Group

Blood (2017) 130 (23): 2491–2498.

https://doi.org/10.1182/blood-2017-02-708552

Published: 2017

Journal Articles

X4P-001: A Novel Molecularly-Targeted Oral Therapy for Whim Syndrome

David Dale, MD, Audrey Anna Bolyard, RN, BS, Emily Dick, BA, Merideth L. Kelley, MS, Vahagn Makaryan, MD, Ramsey Johnson, MSM, Lu Gan, MD PhD, Sudha Parasuraman, MD

Blood (2017) 130 (Supplement 1): 995.

https://doi.org/10.1182/blood.V130.Suppl_1.995.995

Published: 2017

Journal Articles

Whim Syndrome Caused By a 5 Base Pair Deletion in the C-Terminus of Chemokine Receptor CXCR4

Qian Liu, MD, Lizbeeth Lopez, Catherina Pan, Daniel Velez, John S. Corns, Donald T. Ellenburg, Harry L. Malech, MD, Philip M. Murphy, MD, David H. McDermott, MD

Blood (2015) 126 (23): 1003.

https://doi.org/10.1182/blood.V126.23.1003.1003

Published: 2015

Journal Articles

CXCR4 Gene Dosage Is Critical for HSC Engraftment

David H. McDermott, MD, Paejonette Jacobs, PhD, Qian Liu, MD, Jiliang Gao, PhD, Philip M. Murphy, MD

Blood (2015) 126 (23): 3066.

https://doi.org/10.1182/blood.V126.23.3066.3066

Published: 2015

Journal Articles

Allogeneic Stem Cell Transplantation in a Pediatric Patient with Whim Syndrome

Saleh Bhar, MD, Khaled Yassine, MD, Caridad Martinez, MD, Ghadir S. Sasa, MD, Swati Naik, MD, Donald Mahoney, Jr., MD, Carl Allen, MD PhD, Nabil Ahmed, MD, Meenakshi G. Hegde, MD, Helen E. Heslop, MD, Stephen Gottschalk, MD, Robert A. Krance, MD, Kathryn S. Leung

Blood (2015) 126 (23): 5528.

https://doi.org/10.1182/blood.V126.23.5528.5528

Published: 2015

Journal Articles

A Gain-of-Function CCR4 Mutations in Adult T-Cell Leukemia/Lymphoma (ATLL) Enhance the Chemotactic Abilities and PI3K/AKT Activation

Masao Nakagawa, MD PhD, Roland Schmitz, PhD, Wenming Xiao, Carolyn K Goldman, Weihong Xu, Yandan Yang, PhD, Thomas A Waldmann, MD, Louis M. Staudt, MD PhD

Blood (2014) 124 (21): 3566.

https://doi.org/10.1182/blood.V124.21.3566.3566

Published: 2014

Journal Articles

Understanding Neutropenia: The 20 Year Experience of the Severe Chronic Neutropenia International Registry (SCNIR)

David C. Dale, MD, Audrey Anna Bolyard, RN, BS, Cornelia Zeidler, MDMPH, Tracy M. Marrero, Laurence A. Boxer, MD, Peter E. Newburger, MD, Blanche P. Alter, MD MPH, PK Morrow, MD, Mary Ann Bonilla, MD, Yigal Dror, MD FRCP(C), Frank Firkin, MBBS PhDFRACP FRCPA, Sally Kinsey, MD, John E. Levine, MD MS, Daniel C. Link, MD, Lee Reeves, Philip S. Rosenberg, PhD, Akiko Shimamura, MD PhD, Karl Welte, MD

Blood (2014) 124 (21): 2730.

https://doi.org/10.1182/blood.V124.21.2730.2730

Published: 2014

Journal Articles

A WHIM satisfactorily addressed

Hal E. Broxmeyer

Blood (2014) 123 (15): 2286–2288.

https://doi.org/10.1182/blood-2014-02-557579

Published: 2014

Journal Articles

A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor

Blood (2014) 123 (15): 2308–2316.

https://doi.org/10.1182/blood-2013-09-527226

Published: 2014

Includes: Supplemental data

Journal Articles

Somatic Activating Mutations In CXCR4 Are Common In Patients With Waldenstrom’s Macroglobulinemia, and Their Expression In WM Cells Promotes Resistance To Ibrutinib

Yang Cao, MD, Zachary Hunter, Xia Liu, MD, Lian Xu, Guang Yang, PhD, Christina K Tripsas, MA, Robert Manning, Christopher Patterson, Steven Peter Treon, MD, MA, PhD

Blood (2013) 122 (21): 4424.

https://doi.org/10.1182/blood.V122.21.4424.4424

Published: 2013

Journal Articles

Acquired Whim Syndrome: A Possible New Side Effect Of Dasatinib!

Satya Prakash Yadav, MBBS, Mohammed Ramzan, Yogi Raj Chopra, Nivedita Dhingra, Anupam Sachdeva, MD

Blood (2013) 122 (21): 4933.

https://doi.org/10.1182/blood.V122.21.4933.4933

Published: 2013

Journal Articles

The CXCR4 mutations in WHIM syndrome impair the stability of the T-cell immunologic synapse

Marinos Kallikourdis, Anna Elisa Trovato, Fabio Anselmi, Adelaida Sarukhan, Giuliana Roselli, Laura Tassone, Raffaele Badolato, Antonella Viola

Blood (2013) 122 (5): 666–673.

https://doi.org/10.1182/blood-2012-10-461830

Published: 2013

Includes: Multimedia, Supplemental data

Journal Articles

On a WHIM

Charles M. van Slambrouck, Sandeep Gurbuxani

Blood (2013) 121 (6): 875.

https://doi.org/10.1182/blood-2012-03-420091

Published: 2013

Journal Articles

Whole Genome Sequencing Identifies Recurring Somatic Mutations in the C-Terminal Domain of CXCR4, Including a Gain of Function Mutation in Waldenstrom's Macroglobinemia.

Yang Cao, MD, Lian Xu, Xia Liu, MD, Yangsheng Zhou, MD, Guang Yang, MD, Christopher J Patterson, Steven Peter Treon, MD, MA, PhD, Zachary Hunter

Blood (2012) 120 (21): 2715.

https://doi.org/10.1182/blood.V120.21.2715.2715

Published: 2012

Journal Articles

WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4

Qian Liu, Haoqian Chen, Teresa Ojode, Xiangxi Gao, Sandra Anaya-O'Brien, Nicholas A. Turner, Jean Ulrick, Rosamma DeCastro, Corin Kelly, Adela R. Cardones, Stuart H. Gold, Eugene I. Hwang, Daniel S. Wechsler, Harry L. Malech, Philip M. Murphy, David H. McDermott

Blood (2012) 120 (1): 181–189.

https://doi.org/10.1182/blood-2011-12-395608

Published: 2012

Includes: Supplemental data

Journal Articles

Unexpected developments in immune organs in WHIM syndrome

Philip M. Murphy, David H. McDermott

Blood (2012) 119 (24): 5610–5612.

https://doi.org/10.1182/blood-2012-04-420752

Published: 2012

NARROW

Family Studies of Whim Syndrome

Extended Genetic Testing in Severe Congenital Neutropenia May Identify Mutations That Inform Therapy

Determination of Phase 3 Dose for X4P-001 in Patients with WHIM Syndrome

The Effect of the MK0339 Neutrophil Elastase Inhibitor on Proliferation and Maturation of iPSC Derived from Patients with ELANE, TCIRG1 and Whim Syndrome Associated Neutropenia

How I treat warts, hypogammaglobulinemia, infections, and myelokathexis syndrome

X4P-001: A Novel Molecularly-Targeted Oral Therapy for Whim Syndrome

Whim Syndrome Caused By a 5 Base Pair Deletion in the C-Terminus of Chemokine Receptor CXCR4

CXCR4 Gene Dosage Is Critical for HSC Engraftment

Allogeneic Stem Cell Transplantation in a Pediatric Patient with Whim Syndrome

A Gain-of-Function CCR4 Mutations in Adult T-Cell Leukemia/Lymphoma (ATLL) Enhance the Chemotactic Abilities and PI3K/AKT Activation

Understanding Neutropenia: The 20 Year Experience of the Severe Chronic Neutropenia International Registry (SCNIR)

A WHIM satisfactorily addressed

A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor

Somatic Activating Mutations In CXCR4 Are Common In Patients With Waldenstrom’s Macroglobulinemia, and Their Expression In WM Cells Promotes Resistance To Ibrutinib

Acquired Whim Syndrome: A Possible New Side Effect Of Dasatinib!

The CXCR4 mutations in WHIM syndrome impair the stability of the T-cell immunologic synapse

On a WHIM

Whole Genome Sequencing Identifies Recurring Somatic Mutations in the C-Terminal Domain of CXCR4, Including a Gain of Function Mutation in Waldenstrom's Macroglobinemia.

WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4

Unexpected developments in immune organs in WHIM syndrome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only